科研之友
微信
新浪微博
Facebook
分享链接
摘要
Down-regulated expression of the putative tumor suppressor gene spleen tyrosine kinase (SYK) is strongly associated with the development of various cancers, including colorectal cancer (CRC). SYK gene promoter polymorphisms have been shown to be involved in the pathogenesis of multiple malignant tumors. In this study, we investigated associations of SYK gene promoter polymorphisms with the susceptibility to colorectal cancer development in a Southern Han Chinese population. @@@ SNPs in the promoter region of the human SYK gene were identified using in silico analysis tools, linkage disequilibrium analysis, and a search for likely transcription factor binding sites via TFSEARCH in the NCBI SNP database (gene ID: 6850). Based on this information, -803A > T and -534T > C were selected as candidates for further analysis. TaqMan-MGB probe analyses were performed in 567 CRC patients and 569 age- and gender-matched healthy controls for SYK gene promoter genotyping. Associations between CRC risk and SNPs were estimated using an unconditional logistic regression model, and environmental risk factors were included in a multivariate logistic regression model for correction. @@@ The frequencies of the TA and TT genotypes and the T allele of the -803A > T SNP were found to be significantly higher in the CRC patients compared to the healthy individuals of the control group (P = 0.020, 0.023, and 0.013, respectively). Synergistic effects between -803A > T genotypes (i.e., TA + TT) and age (a parts per thousand currency sign60 years; P = 0.039), male gender (P = 0.011), smoking (P = 0.005), drinking alcohol (P = 0.002), and high BMI (a parts per thousand yen24.0 kg/m(2); P = 0.009) were found to increase the risk to develop CRC by stratified analyses. @@@ The SYK -803 A > T genotypes TA and TT are independent risk factors for CRC development in Han Chinese in Southern China, and an association with TA + TT genotypes appears predominant among younger patients, male patients, patients with a high BMI, and patients who smoke or drink alcohol.
